PanTheryx partners to help end pediatric infectious diarrhea in Cambodia

Monday July 15, 2019 0 comments Tags: Boulder, PanTheryx, Mark Braman, Douglas Jackson, Project CURE, DiaResQ, Equity of Access Initiative

BOULDER -- PanTheryx, a U.S. biotechnology company focused on addressing serious GI-related health conditions, announced it is partnering with Zuellig Pharma, a leading healthcare company in Asia, and Project C.U.R.E., the world’s largest provider of donated medical supplies and equipment in developing countries, to help end pediatric infectious diarrhea in Cambodia.Pantheryx_logoUSE

The partnership was developed through PanTheryx’s Equity of Access Initiative, which was created to alleviate the burden of pediatric infectious diarrhea on the poorest and hardest to reach communities around the world.

Diarrhea is a leading killer of children, accounting for approximately 8 percent of deaths under age five worldwide. In Cambodia, pediatric diarrhea is reported as the second-leading cause of death in children under five.

Many of these deaths could be avoided if access to proven prevention and management interventions were made routinely available to all Cambodian children.

PanTheryx’s Equity of Access Initiative provides diarrhea prevention and treatment education, access to PanTheryx’s breakthrough anti-diarrheal nutritional product, DiaResQ, and other medical supplies needed in underserved rural and low-income populations who are most susceptible to diarrheal disease.

In partnership with Zuellig Pharma, Pantheryx will donate 12,000 doses of DiaResQ to the National Pediatric Hospital, a government-run hospital located in Phnom Penh and managed by the Ministry of Health.

To reach rural areas where diarrhea can be even more life threatening, PanTheryx is partnering with Project C.U.R.E. Along with product and supplies, they will provide education on diarrhea management to select clinics and healthcare workers in Siem Reap, one of the poorest provinces in the country.

“I could not be more proud of the work we are doing in Cambodia,” said Mark Braman, CEO of PanTheryx.

“Working toward a greater good and keeping our mission at the forefront of everything we do is what fuels new opportunities, forward movement, and invites collaboration with partners like Zuellig Pharma and Project C.U.R.E.

“To work with partners who share a vision of a world where everyone has access to healthcare, not just those who can afford to buy it, is truly inspirational.”

“Over the last five years, our partnership with PanTheryx has touched thousands of people’s lives through the distribution of the DiaResQ product and our training of nurses, doctors and community health workers,” said Douglas Jackson, president and CEO of Project C.U.R.E.

“This new initiative in Cambodia is a nexus of several leading health organizations. Together we will address the needs of the local communities and empower the resident health professionals to meet the Sustainable Development Goals in their villages and cities."